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Background: Here we report the first case of postoperative endophthalmitis due to Candida pelliculosa after
cataract surgery. We describe the clinical management of this type of candida infection in the eye.
Case presentation: A 57-year-old Turk man was seen at our clinic at the end of the first postoperative month after
cataract surgery. He presented with eye redness, pain and decreased visual acuity. His ophthalmologic examination
revealed moderate tyndall and a mild flare in the anterior chamber. Hypopyon in the capsular bag posterior to the
intraocular lens was seen in the second postoperative month. Despite topical and subconjunctival bacterial
endophthalmitis treatment, there was no improvement in the clinical situation. Candida pelliculosa was isolated
from a sample culture obtained from the anterior chamber. Oral fluconazole could not be administered because
of increased liver enzyme levels and intravenous amphotericin B could not be administered because of an allergic
reaction. Intraocular lens explantation, pars plana vitrectomy and anterior chamber lavage by rupturing the
posterior wall of the microabscesses were performed. Intravitreal and intracameral amphotericin B injections were
given four times in addition to surgical interventions. The patient has been followed for 2 years and his
best-corrected visual acuity was 0.4 at the last visit.
Conclusion: Nearly 1 month after cataract surgery, a patient presented with eye redness and blurred vision, with
corneal endothelial deposits, hypopyon in the capsular bag and microabscesses on the incision sites and corneal
endothelium. Candida pelliculosa should be considered in patients showing these symptoms. Multiple intraocular
amphotericin B (5 μg) administrations can be used safely even in cases with high sensitivity to systemic use.
Rupturing the posterior wall of the abscesses on the corneal endothelium surgically with intraocular lens
explantation and pars plana vitrectomy are recommended.Background
Endophthalmitis is a serious intraocular inflammatory dis-
ease and the most common form is postoperative endoph-
thalmitis. The incidence of post-surgical endophthalmitis
is nearly 0.093% and the organisms responsible are gener-
ally bacteria. Three percent of all cases with endophthal-
mitis after cataract surgery are due to fungi [1,2]. Fungi
have been isolated from 21.8% of all culture positive post-
operative endophthalmitis cases, and mostly Aspergillus
spp. and Candida spp. were determined to be the cause of
fungal endophthalmitis [3,4]. This is the first reported case
with endophthalmitis due to Candida pelliculosa.* Correspondence: halukesgin@trakya.edu.tr
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A 57-year-old Turk male was seen in our clinic with com-
plaints of blurred vision in his left eye. His visual acuity
was 2/20 and he had a nucleocortical and posterior sub-
capsular cataract. A history of systemic hypertension and
past coronary by-pass surgery was present. Uncomplicated
phacoemulsification surgery and foldable posterior cham-
ber intraocular lens (IOL) implantation was performed.
1 mg/0.1 ml intracameral cefuroxime sodium (Cefurol®
1.5 g/15 ml flacon, I.E. Ulagay) was given for prophylaxis.
The eye was closed with tobramycin ophthalmic ointment
3 mg/g and dexamethasone ophthalmic ointment 1 mg/g.
Postoperative best-corrected visual acuity (BCVA) was 16/
20 with minimal corneal edema after the first week.
The patient complained of pain and eye redness for 4 days
on the 27th day after surgery. His BCVA was also decreased
to 10/20. Ophthalmic examination revealed ++++ Tyndall,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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traocular pressure was 14 mmHg OD; 17 mmHg OS.
Fundus examination results were normal and the patient
had no pain. Late onset toxic anterior segment syndrome
(TASS) was suspected. Dexamethasone sodium phosphate
eye drops 0.1% (Onadron® collyrium 1 ml, I.E. Ulagay)
were given hourly, netilmicin sulfate eye drops 0.38%
(Netira® collyrium, SIFI) were given 4 times a day and
cyclopentolate HCl eye drops 1% (Sikloplejin® col-
lyrium, Abdi Ibrahim) were given 3 times a day as a
topical treatment.
Initially, the patient’s symptoms were under control, how-
ever, 3 weeks later, some deposits on the corneal endothe-
lium and dense exudate in the inferior capsular bag were
observed despite topical treatment (Figure 1A). Even after
treatment, endothelial precipitates and exudates increased
and the patient was hospitalized (Figure 1B). Visual acuity
was not at the worst level (6/20) and the patient felt no
pain. A fundus evaluation showed ++ tyndall and + flare.
Because the endophthalmitis was not as severe, we decided
to add subconjunctival vancomycin 25 mg/0.5 ml injection
(Vancomycin® Hcl 1 g flacon, ORNA) twice a day. Ceftazi-
dime 100 mg/0.5 ml injection (Fortum® 1 g flacon, GlaxoS-
mithKline) and dexamethasone 2 mg/0.5 ml injection
(Dekort® 2 ml, 8 mg, Deva) were added to the topical treat-
ment. gatifloxacin 0.3% eye drop hourly (Zymar® collyrium,
Abdi Ibrahim), dexamethasone eye drop hourly (Maxidex®
collyrium, Abdi Ibrahim) and cyclopentolate eye drop 3
times a day (Sikloplejin® collyrium, Abdi Ibrahim). On the
5th day of hospitalization, a sample was taken via paracen-
tesis. Purulent material was aspirated from the capsular bag
and anterior chamber while ceftazidime was injected. C.
pelliculosa was isolated from the sample culture. Systemic
antifungal therapy (fluconazole Tab 100 mg × 4 daily) wasFigure 1 Dense exudate (white arrow) in the inferior capsular bag. (A
(B), hypopyon and deposits on the anterior hyaloids (C), corneal endotheli
(white arrows) (E), sub endothelial encapsulated abscesses (black arrows) (Finitiated but increased levels of liver enzymes (alanine ami-
notransferase: 461, aspartate aminotrasferase: 197) devel-
oped on the 4th day after starting fluconazole. The drug
was stopped and intravenous infusion therapy with liposo-
mal amphotericin B (L-amB; 5 mg/kg/day) was started.
One minute following L-amB infusion, the patient began to
feel pain and fever, with hyperemia in his neck region. The
liposomal amB was then stopped because of this allergic re-
action. The patient refused any other systemic therapy. We
were reticent to initiate intravitreous administration be-
cause of the high sensitivity to antifungal agents and the
side effects of intraocular amB. Then a topical treatment
with fluconazole that was prepared using fluconazole flacon
100 mg/50 ml was started. Despite medical treatment,
the inflammation persisted. An intraocular lens explant-
ation was performed. Two weeks later, the BCVA de-
creased to 2/20 and the patient had 2 mm hypopyon
and deposits on the anterior hyaloid with a blurred fun-
dus (++++tyndall, +++flare; Figure 1C). A pars plana vi-
trectomy (PPV) and an intraocular amB injection (5 μg)
were performed. Hypopyon was resolved and the de-
posits were decreased in number. Topical treatment
with fluconazole, dexamethasone and cyclopentolate
were continued. The BCVA increased to 8/20 and the
fundus was blurry but normal.
One month after the PPV, the patient was observed to
have ciliary flush, an increased anterior chamber reaction,
corneal endothelial microabscesses and minimal optic
nerve head swelling (Figure 1D). A second intravitreal
amB ( 5 μg) dose was injected on that day. Even with top-
ical fluconazole treatment, the patient had pain, decreased
visual acuity and increased corneal endothelial microabs-
cesses 1.5 months after the second intravitreal injection
(Figure 1E). Therefore, anterior chamber lavage, aspiration), endothelial precipitates and increased exudate in the capsular bag
al microabscesses (D), increased corneal endothelial microabscesses
).
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eral intravitreal amB (5 μg) dose with triamcinolone aceto-
nide 4 mg were given. An increase in corneal endothelial
microabscesses and pain occurred again after 1 month
(Figure 1F). Then, anterior chamber lavage and aspiration
of abscesses by rupturing the posterior wall were per-
formed and intracameral amB was injected for the 4th
time. In the fundus, there was a ++ vitreous cellular reac-
tion and a pale optic nerve head. Thereafter, no relapse
was observed. The Infection management took place for
8 months. Moreover, there was no recurrence of endoph-
thalmitis during 3 years of follow-up. The BCVA of the
patient remained at 8/20.
Conclusions
Fungus is the cause of 7–13% of culture positive cases of
postoperative endophthalmitis and the common fungal
species that are isolated are Aspergillus spp., Cephalos-
porium spp. and Candida spp [2,3].
Possible sources of exogenous fungal infection are con-
taminated intraocular irrigation solutions [5], intraocular
lenses [6], ventilation systems or hospital construction ac-
tivities [7]. We could not find any predisposing factor to
account for the fungal endophthalmitis in this case.
Colonization at the time of cataract surgery or postopera-
tive self-inoculation by the patient may have occurred.
The mean time interval between cataract surgery and
the development of symptoms in exogenous fungal en-
dophthalmitis is 19.5 days [3]. In candida endophthalmi-
tis, it ranges from 3 days to 50 days [5,7]. The interval
was 23 days in our C. pelliculosa case.
Corneal involvement, anterior chamber exudates, hypop-
yon and fibrinous reaction localized around the IOL have
been seen in fungal endophthalmitis cases [7].
Parental antifungal treatment is recommended for 4–
6 weeks in candida endophthalmitis. We were unable to
manage allergic reactions due to L-AmB because of the
hepatotoxicity of fluconazole and patient refusal. In-
creased liver enzymes due to fluconazole, such as in our
case, have been seen in 2 of 27 cases [7].
Intraocular AmB injections might be needed several
times in fungal endophthalmitis. In one case with exogen-
ous fungal endophthalmitis, three intravitreal AmB injec-
tions were needed [8]. In another case with candida
endophthalmitis, 67 mg amB was injected 11 times in total
[9]. In a case series, two or more injections were performed
in 2 of 27 eyes [7]. In our case, despite topical treatment,
inflammation recurred and we performed intravitreal amB
injections 4 times.
A combination of PPV and antifungal agents appears
to be the best therapy for exogenous fungal endophthal-
mitis. The role of corticosteroids is controversial. Our
aim in using corticosteroids was to diminish tissue de-
struction due to damage by fungal toxins.It has been reported that visual outcomes were un-
favorable in fungal postoperative endophthalmitis cases
following PPV [3]. The final BCVA was better than 6/18
in only in 5 of 27 eyes [7]. Our final BCVA was 8/20 and
we consider this a favorable outcome.
In summary, 23 days after cataract surgery, the patient
presented with eye redness, pain and blurred vision. Cor-
neal endothelial deposits, hypopyon in the capsular bag
and microabscesses on the incision sites and corneal endo-
thelium were thought to be caused by C. pelliculosa. PPV
with IOL explantation and multiple amB (5 μg) injections
into the anterior chamber and vitreous cavity with ruptur-
ing of the posterior wall of the abscesses on the endothe-
lium are recommended.
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